🔴 Capricor Therapeutics is trading 5% down in pre-market with no fresh company announcement identified

Capricor Therapeutics is trading 5.43% lower at $6.51 in pre-market on October 14, with no fresh company announcement identified to explain the move.

• It closed at $6.88 on October 13, down 7.90% from the prior session, continuing a decline over recent sessions.
• The latest listed press release, dated October 5, covered positive HOPE-3 extension data; no October 13 or 14 release was listed. Major indices were modestly higher.